Síndrome de embolismo graso con predominio de síntomas neurológicos. [Fat embolism syndrome with predominance of neurological symptoms].

Article Sidebar

PDF (Español (España)) PDF_EN
Published: Nov 8, 2016
DOI: https://doi.org/10.15417/595

Main Article Content

Diego Alejandro Rangel Rivera
Universidad industrial de Santander
http://orcid.org/0000-0002-4923-1438
Stiven Fuentes Abreu
Hospital regional de San Gil
http://orcid.org/0000-0002-2141-4160
Julian Guerrero Caballero
http://orcid.org/0000-0001-7635-2297
Juan Carlos Rodríguez Durán
Hospital region de San Gil
http://orcid.org/0000-0001-9473-2349

Abstract

El síndrome de embolismo graso se refiere a un conjunto de signos y síntomas que se presentan de manera secundaria a la liberación de lípidos dentro de la circulación sanguínea. Este se presenta en alrededor del 1% de los pacientes con fracturas de fémur. La tríada clásica de este síndrome incluye dificultad respiratoria con hipoxemia, alteración neurológica y rash petequial. A pesar de las descripciones aisladas donde se documenta mejoría de los síntomas posterior a la administración de corticoesteroides, no existe clara evidencia de la utilidad de estos medicamentos por lo que el manejo actual es de soporte cardiovascular y respiratorio. Se presenta el caso de un paciente adulto jóven con síndrome de embolismo graso con manifestaciones respiratorias mínimas posterior a fractura traumática de fémur. 

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Article Details

How to Cite
Rangel Rivera, D. A., Fuentes Abreu, S., Guerrero Caballero, J., & Rodríguez Durán, J. C. (2016). Síndrome de embolismo graso con predominio de síntomas neurológicos. [Fat embolism syndrome with predominance of neurological symptoms]. Revista De La Asociación Argentina De Ortopedia Y Traumatología, 81(4), 310-314. https://doi.org/10.15417/595
Issue
Vol 81 No 4 (2016)
Section
Case Presentations
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Manuscript acceptance by the Journal implies the simultaneous non-submission to any other journal or publishing house. The RAAOT is under the Licencia Creative Commnos Atribución-NoComercial-Compartir Obras Derivadas Igual 4.0 Internacional (CC-BY-NC.SA 4.0) (http://creativecommons.org/licences/by-nc-sa/4.0/deed.es). Articles can be shared, copied, distributed, modified, altered, transformed into a derivative work, executed and publicly communicated, provided a) the authors and the original publication (Journal, Publisher and URL) are mentioned, b) they are not used for commercial purposes, c) the same terms of the license are maintained.

In the event that the manuscript is approved for its next publication, the authors retain the copyright and will assign to the journal the rights of publication, edition, reproduction, distribution, exhibition and communication at a national and international level in the different databases. data, repositories and portals.

It is hereby stated that the mentioned manuscript has not been published and that it is not being printed in any other national or foreign journal.

The authors hereby accept the necessary modifications, suggested by the reviewers, in order to adapt the manuscript to the style and publication rules of this Journal.

References

1. Talbot M, Schemitsch EH. Fat embolism syndrome: history, definition, epidemiology. Injury. 2006;37 Suppl 4:S3-7.

2. Jacobson DM, Terrence CF, Reinmuth OM. The neurologic manifestations of fat embolism. Neurology. 1986;36(6):847-51.

3. Kotan D, Ayas ZO, Sayan S, Inanmaz ME, et al. Cerebral fat embolism diagnosed by cognitive disorder. The Eurasian journal of medicine. 2014;46(2):135-7.

4. Kamano M, Honda Y, Kitaguchi M, Kazuki K. Cerebral fat embolism after a nondisplaced tibial fracture: case report. Clinical orthopaedics and related research. 2001(389):206-9.

5. Garcia-Estevez DA, Castro-Menendez M, Canal-Perez MG. [Fat embolism syndrome in the brain: a clinical case triggered after fracture of the humerus and without any associated respiratory distress]. Revista de neurologia. 2015;60(1):45-6.

6. Gurd AR. Fat embolism: an aid to diagnosis. The Journal of bone and joint surgery British volume. 1970;52(4):732-7.

7. Stein PD, Yaekoub AY, Matta F, Kleerekoper M. Fat embolism syndrome. The American journal of the medical sciences. 2008;336(6):472-7.

8. Campo-López C, Flors-Villaverde P, Calabuig-Alborch JR. Síndrome de embolia grasa tras fractura ósea. Rev Clin Esp. 2012;212:482-7.
9. Kosova E, Bergmark B, Piazza G. Fat embolism syndrome. Circulation. 2015;131(3):317-20.

10. Saigal R, Mittal M, Kansal A, Singh Y, et al. Fat embolism syndrome. The Journal of the Association of Physicians of India. 2008;56:245-9.

11. Mellor A, Soni N. Fat embolism. Anaesthesia. 2001;56(2):145-54.

12. George J, George R, Dixit R, Gupta RC, et al. Fat embolism syndrome. Lung India : official organ of Indian Chest Society. 2013;30(1):47-53.

13. Filomeno L, Carelli C, Silva C, Filho T, et al. Fat embolism: a review for current orthopaedic practice. Acta ortopedica brasileira. 2005;13:196-208.

14. Lee J. Gradient-echo MRI in defining the severity of cerebral fat embolism. Journal of clinical neurology. 2008;4(4):164-6.

15. Finlay ME, Benson MD. Case report: magnetic resonance imaging in cerebral fat embolism. Clinical radiology. 1996;51(6):445-6.

16. Bardana D, Rudan J, Cervenko F, Smith R. Fat embolism syndrome in a patient demonstrating only neurologic symptoms. Canadian journal of surgery Journal canadien de chirurgie. 1998;41(5):398-402.

17. Dhar D. Fat embolism syndrome. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. 2012;22(12):800-2.

18. Nikolic S, Zivkovic V, Babic D, Djonic D, et al. Systemic fat embolism and the patent foramen ovale--a prospective autopsy study. Injury. 2012;43(5):608-12.

19. Habashi NM, Andrews PL, Scalea TM. Therapeutic aspects of fat embolism syndrome. Injury. 2006;37 Suppl 4:S68-73.

20. Kubota T, Ebina T, Tonosaki M, Ishihara H, et al. Rapid improvement of respiratory symptoms associated with fat embolism by high-dose methylpredonisolone: a case report. Journal of anesthesia. 2003;17(3):186-9.

21. Riska EB, Myllynen P. Fat embolism in patients with multiple injuries. The Journal of trauma. 1982;22(11):891-4.

22. Pitto RP, Hamer H, Fabiani R, Radespiel-Troeger M, et al. Prophylaxis against fat and bone-marrow embolism during total hip arthroplasty reduces the incidence of postoperative deep-vein thrombosis: a controlled, randomized clinical trial. The Journal of bone and joint surgery American volume. 2002;84-A(1):39-48.

23. Pitto RP, Schramm M, Hohmann D, Kossler M. Relevance of the drainage along the linea aspera for the reduction of fat embolism during cemented total hip arthroplasty. A prospective, randomized clinical trial. Archives of orthopaedic and trauma surgery. 1999;119(3-4):146-50.

24. Bederman SS, Bhandari M, McKee MD, Schemitsch EH. Do corticosteroids reduce the risk of fat embolism syndrome in patients with long-bone fractures? A meta-analysis. Canadian journal of surgery Journal canadien de chirurgie. 2009;52(5):386-93.

25. Akoh CC, Schick C, Otero J, Karam M. Fat embolism syndrome after femur fracture fixation: a case report. The Iowa orthopaedic journal. 2014;34:55-62.